Anebulo Pharmaceuticals, Inc. ANEB 深 沪
等待开盘 02-05 09:30:00 美东时间
0.9501
+0.000
+0.01%
华盛通- 最 高0.9648
- 今 开0.9215
- 成交量 3.30万股
- 最 低 0.8601
- 昨 收 0.95
- 总市值 3903.46万
- 52周最高 3.42
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.8003
- 委 比 -57.10%
- 总股本 4108.47万
- 历史最高 9.33
- 量 比 0.36
- 振 幅 11.02%
- 历史最低 0.8001
- 每 手 1
- 风险率 0.65%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Vyome Holdings (NASDAQ:HIND) stock increased by 16.1% to $2.23 during ...
02-02 20:05
Anebulo Pharmaceuticals Completes Oversubscribed Share Repurchase Tender
Anebulo Pharmaceuticals ( ($ANEB) ) has shared an announcement. On January 29, ...
01-29 23:03
Anebulo Pharmaceuticals Buys Back 300,000 Shares for $1.05 Million
Anebulo Pharmaceuticals Buys Back 300,000 Shares for $1.05 Million Anebulo Pharmaceuticals Inc. has announced the preliminary results of its voluntary self-tender offer, with the company expecting to purchase 300,000 shares of its common stock at a purchase price of $3.50 per share, for an aggregate
01-27 22:49
Anebulo Pharmaceuticals Announces Oversubscribed Self-Tender Offer Results
Anebulo Pharmaceuticals ( ($ANEB) ) has shared an update. On January 27, 2026, ...
01-27 22:48
How Do Investors Really Feel About Anebulo Pharmaceuticals Inc?
Anebulo Pharmaceuticals Inc's (NYSE:ANEB) short interest as a percent of float ...
01-22 23:00
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers SciSparc (NASDAQ:SPRC) shares rose 6.3% to $1.46 during Monday's after...
2025-12-30 05:05
How Is The Market Feeling About Anebulo Pharmaceuticals Inc?
Anebulo Pharmaceuticals Inc's (NYSE:ANEB) short interest as a percent of float ...
2025-12-27 01:00
Anebulo To Commence $3.50/Shr Cash Tender Offer For Up To 300K Shares As Part Of Plan To Go Private In Lieu Of Reverse Stock Split At Ratio Of Not Less Than 1-For-2,500 And Not Greater Than 1-For-7,500
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the "Company" or "Anebulo"), today announced
2025-12-22 22:05
Anebulo Pharmaceuticals Q1 EPS $(0.05) Beats $(0.12) Estimate
Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.12) by 58.33 percent. This is a 37.5 percent increase over losses of $(0.08) per share
2025-11-14 05:33
Anebulo Pharmaceuticals Advances Cannabis Toxicity Treatment
Anebulo Pharmaceuticals, Inc. ( ($ANEB) ) has released its Q4 earnings. Here is...
2025-10-01 14:51
